HomeInsightsStock Comparison

Fdc Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Fdc Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Last Updated on: Jun 21, 2025

Key Highlights

  • The Latest Trading Price of FDC Ltd is ₹ 455.25 as of 20 Jun 15:30.
  • The P/E Ratio of FDC Ltd changed from 14 on March 2020 to 22.6 on March 2024 . This represents a CAGR of 10.05% over 5 yearsThe P/E Ratio of Solara Active Pharma Sciences Ltd changed from 10.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of FDC Ltd changed from ₹ 3350 crore on March 2020 to ₹ 6912 crore on March 2024 . This represents a CAGR of 15.59% over 5 yearsThe Market Cap of Solara Active Pharma Sciences Ltd changed from ₹ 1190 crore on March 2020 to ₹ 1340 crore on March 2024 . This represents a CAGR of 2.41% over 5 years.
  • The revenue of FDC Ltd for the Mar '25 is ₹ 507.97 crore as compare to the Dec '24 revenue of ₹ 482.94 crore. This represent the growth of 5.18% The revenue of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 278.96 crore as compare to the Dec '24 revenue of ₹ 301.8 crore. This represent the decline of -7.57%.
  • The ebitda of FDC Ltd for the Mar '25 is ₹ 70.06 crore as compare to the Dec '24 ebitda of ₹ 65.48 crore. This represent the growth of 6.99% The ebitda of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 51.32 crore as compare to the Dec '24 ebitda of ₹ 59.17 crore. This represent the decline of -13.27%.
  • The net profit of FDC Ltd changed from ₹ 109.81 crore to ₹ 38.67 crore over 8 quarters. This represents a CAGR of -40.66% The net profit of Solara Active Pharma Sciences Ltd changed from ₹ -19.11 crore to ₹ -2.1 crore over 8 quarters. This represents a CAGR of -66.85% .
  • The Dividend Payout of FDC Ltd changed from 5.54 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Solara Active Pharma Sciences Ltd changed from 4.77 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About FDC Ltd

  • FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
  • The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
  • It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
  • It has established a global footprint in both domestic and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry. Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.

About Solara Active Pharma Sciences Ltd

  • Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
  • The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
  • The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
  • It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches.

FDC Ltd News Hub

News

Volumes jump at FDC Ltd counter

Bajaj Finance Ltd, P I Industries Ltd, Anand Rathi Wealth Ltd, Cipla Ltd are among the oth...

Read more

16 Jun 2025 11:00

News

FDC to conduct board meeting

FDC will hold a meeting of the Board of Directors of the Company on 28 May 2025. Powered b...

Read more

23 May 2025 17:29

News

FDC to declare Quarterly Results

FDC will hold a meeting of the Board of Directors of the Company on 12 February 2025. Powe...

Read more

08 Feb 2025 11:03

News

FDC gets USFDA nod for anti-bacterial drug

The announcement was made at the fag end of market hours yesterday. Cefixime is used to tr...

Read more

19 Dec 2024 10:47

News

Board of FDC recommends first interim dividend

FDC announced that the Board of Directors of the Company at its meeting held on 6 November...

Read more

07 Nov 2024 15:15

News

FDC schedules board meeting

FDC will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powere...

Read more

29 Oct 2024 15:20

Solara Active Pharma Sciences Ltd News Hub

News

Solara Active Pharma's Ambernath facility clears USFDA inspection

The Agency with their designated investigator inspected the facility from 5th to 9th May 2...

Read more

12 May 2025 08:36

News

Solara Active Pharma Sciences to conduct board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

07 May 2025 17:24

News

Solara Active Pharma Sciences to convene board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

27 Mar 2025 10:23

News

Solara Active Pharma Sciences to hold board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

22 Mar 2025 10:11

News

Solara Active Pharma Sciences to incorporate wholly owned subsidiary

Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in rel...

Read more

07 Feb 2025 11:00

News

Solara Active Pharma Sciences announces board meeting date

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

16 Jan 2025 16:10

SWOT Analysis Of FDC Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Solara Active Pharma Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for FDC Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Solara Active Pharma Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of FDC Ltd and Solara Active Pharma Sciences Ltd

Which company has a larger market capitalization, FDC Ltd or Solara Active Pharma Sciences Ltd?

Market cap of FDC Ltd is 7,411 Cr while Market cap of Solara Active Pharma Sciences Ltd is 2,371 Cr

What are the key factors driving the stock performance of FDC Ltd and Solara Active Pharma Sciences Ltd?

The stock performance of FDC Ltd and Solara Active Pharma Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for FDC Ltd and Solara Active Pharma Sciences Ltd?

As of June 21, 2025, the FDC Ltd stock price is INR ₹455.25. On the other hand, Solara Active Pharma Sciences Ltd stock price is INR ₹530.7.

How do dividend payouts of FDC Ltd and Solara Active Pharma Sciences Ltd compare?

To compare the dividend payouts of FDC Ltd and Solara Active Pharma Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions